| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.89▲ | 2.90▲ | 2.90▲ | 3.10▼ | 3.32▼ |
| MA10 | 2.92▲ | 3.00▼ | 3.00▼ | 3.12▼ | 3.35▼ |
| MA20 | 3.05▼ | 3.09▼ | 3.08▼ | 3.48▼ | 3.56▼ |
| MA50 | 3.09▼ | 3.15▼ | 3.25▼ | 3.39▼ | 3.86▼ |
| MA100 | 3.41▼ | 3.53▼ | 3.53▼ | 3.61▼ | 4.23▼ |
| MA200 | 3.64▼ | 3.59▼ | 3.44▼ | 3.70▼ | 6.95▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.012▼ | -0.022▼ | -0.014▼ | -0.061▼ | -0.043▼ |
| RSI | 40.271▼ | 39.083▼ | 37.584▼ | 33.893▼ | 39.676▼ |
| STOCH | 26.786 | 10.260▼ | 10.260▼ | 24.728 | 40.941 |
| WILL %R | -75.000▼ | -79.798▼ | -79.798▼ | -92.647▼ | -80.861▼ |
| CCI | -39.924 | -81.258 | -81.869 | -113.736▼ | -112.190▼ |
|
Monday, October 21, 2019 04:00 AM
and CAMBRIDGE, Mass., Oct. 21, 2019 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 21/10/19 | 2.92 | 2.94 | 2.82 | 2.92 | 124,251 |
| 18/10/19 | 3.14 | 3.221 | 3.03 | 3.08 | 69,300 |
| 17/10/19 | 3.25 | 3.30 | 3.07 | 3.11 | 67,600 |
| 16/10/19 | 3.13 | 3.34 | 3.121 | 3.24 | 95,700 |
| 15/10/19 | 3.13 | 3.26 | 2.92 | 3.16 | 81,700 |
| 14/10/19 | 3.07 | 3.20 | 2.91 | 3.10 | 82,000 |
| 11/10/19 | 3.13 | 3.23 | 3.05 | 3.06 | 69,800 |
| 10/10/19 | 3.11 | 3.25 | 3.06 | 3.15 | 63,300 |
| 09/10/19 | 3.29 | 3.47 | 3.07 | 3.12 | 112,500 |
| 08/10/19 | 3.31 | 3.427 | 3.275 | 3.28 | 92,900 |
|
|
||||
|
|
||||
|
|